Use of nootkatone to treat mosquito infestations

US11896008B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11896008-B2
Application numberUS-202117494048-A
CountryUS
Kind codeB2
Filing dateOct 5, 2021
Priority dateSep 2, 2016
Publication dateFeb 13, 2024
Grant dateFeb 13, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for treating and preventing mosquito infestations are disclosed herein. Also disclosed herein are compositions and methods to reduce or prevent the spread of diseases for which mosquitoes may act as a vector.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of killing a mosquito larva, comprising: applying an effective amount of a nootkatone-containing composition to a mosquito breeding site comprising one or more mosquito larvae, wherein the one or more mosquito larvae are killed by the nootkatone applied to the mosquito breeding site. 2. The method of claim 1 , wherein the effective amount of the nootkatone-containing composition exposes the one or more mosquito larvae to a nootkatone concentration of about 0.01% to 0.03% (v/v) nootkatone at the mosquito breeding site. 3. The method of claim 1 , wherein the one or more mosquito larvae are members of the genera Anopheles, Aedes, Culex , or Haemagogus. 4. The method of claim 3 , wherein the one or more mosquito larvae are Aedes aegypti larvae. 5. The method of claim 1 , wherein the nootkatone is wholly or partially solubilised, liquefied, and/or dispersed in the nootkatone-containing composition. 6. The method of claim 5 , wherein the nootkatone-containing composition comprises ethanol, dichloromethane, ethyl acetate, hexane, an oil, a non-polar solvent, a surfactant, or a mixture or blend thereof. 7. The method of claim 5 , wherein the nootkatone-containing composition comprises a non-toxic, biodegradable nootkatone-solubilizing carrier or surfactant or a mixture or blend thereof. 8. The method of claim 1 , wherein the nootkatone-containing composition is applied to the mosquito breeding site about once per day, about once every 3 days, about once per week, about twice per week, about once per two weeks, about once per month, about once per two months, about once per three months, or about once per season. 9. The method of claim 8 , wherein the nootkatone-containing composition is applied using a dispenser. 10. The method of claim 9 , wherein the dispenser is a pouch, a puck, a pellet, a block, a granule, a vesicle, or a capsule. 11. The method of claim 9 , wherein the dispenser is refillable. 12. A method of killing a mosquito pupa, comprising: applying an effective amount of a nootkatone-containing composition to a mosquito breeding site comprising one or more mosquito pupae, and wherein the one or more mosquito pupae are killed by the nootkatone applied to the mosquito breeding site. 13. The method of claim 12 , wherein the effective amount of the nootkatone-containing composition exposes the one or more mosquito pupae to a nootkatone concentration of about 0.01% to 0.03% (v/v) nootkatone at the mosquito breeding site. 14. The method of claim 12 , wherein the one or more mosquito pupae are members of the genera Anopheles, Aedes, Culex , or Haemagogus. 15. The method of claim 14 , wherein the one or more mosquito pupae are Aedes aegypti pupae. 16. The method of claim 12 , wherein the nootkatone is wholly or partially solubilised, liquefied, and/or dispersed in the nootkatone-containing composition. 17. The method of claim 16 , wherein the nootkatone-containing composition comprises ethanol, dichloromethane, ethyl acetate, hexane, an oil, a non-polar solvent, a surfactant, or a mixture or blend thereof. 18. The method of claim 16 , wherein the nootkatone-containing composition comprises a non-toxic, biodegradable nootkatone-solubilizing carrier or surfactant or a mixture or blend thereof. 19. The method of claim 12 , wherein the nootkatone-containing composition is applied to the mosquito breeding site about once per day, about once every 3 days, about once per week, about twice per week, about once per two weeks, about once per month, about once per two months, about once per three months, or about once per season. 20. The method of claim 19 , wherein the nootkatone-containing composition is applied using a dispenser. 21. The method of claim 20 , wherein the dispenser is a pouch, a puck, a pellet, a block, a granule, a vesicle, or a capsule. 22. The method of claim 20 , wherein the dispenser is refillable. 23. A method of reducing the rate of mosquito egg hatching, comprising: applying an effective amount of a nootkatone-containing composition to a mosquito breeding site comprising one or more unhatched mosquito eggs, wherein the rate of mosquito egg hatching of the one or more unhatched mosquito eggs is reduced by the nootkatone applied to the mosquito breeding site. 24. The method of claim 23 , wherein the effective amount of the nootkatone-containing composition exposes the one or more unhatched mosquito eggs to a nootkatone concentration of about 0.01% to 0.03% (v/v) nootkatone at the mosquito breeding site. 25. The method of claim 23 , wherein the one or more unhatched mosquito eggs are members of the genera Anopheles, Aedes, Culex , or Haemagogus. 26. The method of claim 25 , wherein the one or more unhatched mosquito eggs are Aedes aegypti eggs. 27. The method of claim 23 , wherein the nootkatone is wholly or partially solubilised, liquefied, and/or dispersed in the nootkatone-containing composition. 28. The method of claim 27 , wherein the nootkatone-containing composition comprises ethanol, dichloromethane, ethyl acetate, hexane, an oil, a non-polar solvent, a surfactant, or a mixture or blend thereof. 29. The method of claim 27 , wherein the nootkatone-containing composition comprises a non-toxic, biodegradable nootkatone-solubilizing carrier or surfactant or a mixture or blend thereof. 30. The method of claim 23 , wherein the nootkatone-containing composition is applied to the mosquito breeding site about once per day, about once every 3 days, about once per week, about twice per week, about once per two weeks, about once per month, about once per two months, about once per three months, or about once per season. 31. The method of claim 30 , wherein the nootkatone-containing composition is applied using a dispenser. 32. The method of claim 31 , wherein the dispenser is a pouch, a puck, a pellet, a block, a granule, a vesicle, or a capsule. 33. The method of claim 31 , wherein the dispenser is refillable. 34. A method of reducing mosquito pupae eclosion, comprising: applying an effective amount of a nootkatone-containing composition to a mosquito breeding site comprising one or more mosquito pupae, wherein eclosion of the one or more mosquito pupae is reduced by the nootkatone applied to the mosquito breeding site. 35. The method of claim 34 , wherein the effective amount of the nootkatone-containing composition exposes the one or more mosquito pupae to a nootkatone concentration of about 0.01% to 0.03% (v/v) nootkatone at the mosquito breeding site. 36. The method of claim 34 , wherein the one or more mosquito pupae are members of the genera Anopheles, Aedes, Culex , or Haemagogus. 37. The method of claim 36 , wherein the one or more mosquito pupae are Aedes aegypti pupae. 38. The method of claim 34 , wherein the nootkatone is wholly or partially solubilised, liquefied, and/or dispersed in the nootkatone-containing composition. 39. The method of claim 38 , wherein the nootkatone-containing composition comprises ethanol, dichloromethane, ethyl acetate, hexane, an oil, a non-polar solvent, a surfactant, or a mixture or blend thereof. 40. The method

Assignees

Inventors

Classifications

  • A01N35/06Primary

    containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals · CPC title

  • Dispersions, {emulsions, suspoemulsions, suspension concentrates} or gels (foams A01N25/16) · CPC title

  • characterised by the surfactants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11896008B2 cover?
Compositions and methods for treating and preventing mosquito infestations are disclosed herein. Also disclosed herein are compositions and methods to reduce or prevent the spread of diseases for which mosquitoes may act as a vector.
Who is the assignee on this patent?
Evolva Sa
What technology area does this patent fall under?
Primary CPC classification A01N35/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).